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The resurgence of Second wave of Covid-19 in India 
has been spreading like wild fire and effect are more 
in rural population, highlighting the need for urgent 
evidence-based guidelines for home care to reduce 
overcrowding  of  hospitals.[1]  It  is  observed  that  the  
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mutant virus in second wave has more effective 
transmission capability and its incubation period is 
also lesser as compared to the initial wave. There has 
been a widespread disregard to the ‘Covid 
Appropriate Behaviours or CAB’ by the public which 
results in more severe illness, reducing the 
neutralisation of antibodies and effectiveness of 
treatment/vaccine. The breathing difficulties are 
commonly seen in 2nd wave, right from the beginning 
of infection in most of the patients.[2] There existed a 
shortage of hospital beds, ICU capacity, medical 
oxygen and modern medicine to begin with. The 
incidence of angioinvasive maxillofacial fungal 
infections (Mucor mycosis) showed a positive 
development in some diabetic patients treated for 
SARS-CoV-2 with   high dose corticosteroid 
administration.[3] Patient had to struggle at home as 
hospitals were loaded beyond their capacity and 
A B S T R A C T  
Ayurvedic herbal combinations like Kasaya, Churna  and Vati are very useful even in the moderate to 
severe patients with oxygen support. It was reported that Ayurveda medication can prevent further 
progression of inflammatory phase (cytokine storm) and prothrombic phase (Organ failure) of Covid-
19 infection. Rasa Rasayana are thought to be more potent and quicker in action as compared to 
Ayurvedic herbal combination in Jvara Chikitsa (Fever) and are potent Immuno boosters also.  A 42 
years male consulted an Ayurvedic Physician with breathing difficulties and redness of eyes and face.  
His SPO2 was 85%and HRCT of thorax’s severity score was 14/25 with Diabetes and Hypertension as 
pre-existing co-morbidities. The patient had received Ayush-64, Siddha Makardwaja, Swasa Kasa 
Chintamani Rasa for the first three days of treatment along with oxygen therapy after that Dasamoola 
Haritaki was added. The patient showed clinical improvement within a day of administration of 
Ayurvedic medicines and felt good. His cough and breathing difficulties have substantially reduced and 
his SPO2 became stable between 94 and 96% in two days.  This case report highlights the clinical 
success story as a result of administration of Ayurvedic Rasa-Rasayana and herbal combination in 
early Inflammatory phase of COVID-19 infection without the use of synthetic steroid and reducing the 
oxygen requirement needed for home care set up through telehealth service. It may sensitize the 
reader for early detection and management of similar or identical cases. 
Key words: AYUSH-64, Siddha Makardwaja Rasa, Swasa Kasa Chintamoni Rasa, COVID-19, Hypoxia, 
Oxygen therapy, Home Care, Case Study. 
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many people sought Ayurvedic Intervention. The 
preliminary Randomised Clinical Trial report of CCRAS 
showed that AYUSH-64 can reduce progression of 
disease, quicker improvements in SPO2 and faster 
resolution of symptoms with no causalities.[4] 
Ayurvedic herbal combinations like Kasaya, Churna 
and Vati are very useful even in the moderate to 
severe patients on oxygen support and can prevent 
further progression of inflammatory phase (cytokine 
storm) and prothrombic phase (Organ failure)  of 
Covid-19 infection.[5] Rasa Rasayana are more potent 
and quick in action as compared to Ayurvedic herbal 
combination in Jvara Chikitsa (Fever)[6] and are potent 
Immuno Boosters.[7] Severe illness in COVID-19 
typically occurs approximately 1 week after the onset 
of symptoms. The most common symptom is 
dyspnoea, which is often accompanied by hypoxemia. 
Patients with severe disease typically require 
supplemental oxygen and should be monitored 
closely for worsening respiratory status because some 
patients may progress to acute respiratory distress 
syndrome (ARDS). The optimal oxygen saturation 
(SPO2) in adults with COVID-19 is uncertain. However, 
a target SPO2 of 92% to 96% seems logical considering 
that indirect evidence from experience in patients 
without COVID-19 suggests that an SPO2 <92% or 
>96% may be harmful.[8] In the mild and moderate 
stages of disease, normal oxygen supportive measures 
(facemask oxygen) may be advantageous. 
WHO recommends supplemental oxygen therapy 
immediately for patients with respiratory distress, 
hypoxaemia or shock with a target SPO2 > 94%.[9] It is 
very crucial to train family member or nurses to 
screen patients and initiate quick management to the 
high risk patients under home care settings through 
telehealth to prevent hospitalisation, reduce 
economic burden and exposure of emergency care.[10] 
Pronging and Yogic postures are medically accepted 
practice to improves breathing comfort and 
oxygenation. It is extremely beneficial in COVID-19 
patients with compromised breathing comfort, 
especially during home isolation.[11] This case report 
highlights the clinical success story of administration 
of Ayurvedic Rasa Rasayana and herbal combination 
in early Inflammatory phase of COVID-19 infection 
without the use of synthetic steroid along with 
optimum oxygen in home care under the guidance of 
telehealth service.  
Patient Information 
A forty-two years old male patient suffering from 
body ache and mild fever (100°F) on 1st April 2021 
ignored the problem and avoided Corona Verification 
Test fearing social stigma. He self-medicated by 
consuming Paracetamol (650mg), Azithromycin, Poly 
Vitamin with Zinc and Vitamin C without consulting 
any doctor for five days. On 5th April his fever 
subsided but cough, fatigue, nausea, sore throat and 
loss of taste and smell developed. He is a known case 
of Diabetes controlled only with diet and exercise 
without medication or medical advice. He felt 
profound weakness and was unable to stand up on 
8/4/2021 and Rapid antigen test for Corona was 
positive. There was redness of face and eyes, along 
with tightness of chest and breathing difficulties on 9th 
April 2021 (9th day of initial symptom). The Patient’s 
wife consulted me on 10th day of initial symptom (10th 
April 2021) when he became serious.  
Clinical Findings 
SPO2 and blood sugar was recorded immediately. His 
SPO2 was below 90% but it reached 85% often. His 
respiration rate was 30/min, Pulse rate was 98/min 
and blood pressure was 154/102 mmHg. The patient 
then consulted me with video call wherein I found 
redness of face with conjunctivitis, sluggish voice and 
congestion. He was advised to do chest X-ray 
immediately and found consolidation opacity and 
Ground Glass Opacity (GGO). So, I advised the patient 
for further investigations and arrangement of oxygen 
cylinder otherwise get admitted in COVID hospital. 
But the patient was not willing to get admitted and 
gave his written consent for Ayurvedic treatment.   
Diagnostic Method 
He was sent for RT-PCR test and HRCT of thorax for 
covid scoring on 11th day of his sufferings. His RT-PCR 
test was positive HRCT of thorax (COVID Screening) 
showed GGO with fibrotic band in bilateral lungs. His 
CT severity Score was 14/25, which showed moderate 
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stage of COVID-19. His Hb%-11.2g/dl, TLC-5210, total 
platelet count 2.64 laks/cum mm, FBS-260mg/dl and 
PPBS-320mg/dl, HBA1C-10, CRP-36(<8), D.Dimer-321 
(<500) and IL6 -10(<6). The Liver function test, renal 
function test and blood electrolytes were within 
normal limits. His SPO2 was below 90% always. The 
patient was diagnosed as severe Covid-19 infection in 
Inflammatory phase with severe hypoxia and 
moderate lung injury.  The Ayurveda diagnosis was 
Pittaja Sotha as per symptoms.   
Ayurvedic Intervention and Time line  
The treatment was advised as per symptoms of the 
patient after receiving his consent and undertaking 
from the patient’s wife. The initial treatment on 10th 
day of initial symptoms was AYUSH-64 - 2 Tablets 
T.D.S. with Siddha Makardwaja 125mg OD and 
advised to drink Haldi Milk 200ml twice. As patient 
developed hypoxia, then continuous oxygen therapy 
through mask and insulin 10 units TDS to control the 
hypoxia and sugar respectively by consulting a 
Pulmologist on 11th day of initial symptoms. The 
techniques of Oxygen therapy and insulin delivery 
were taught to patient’s wife as Para Medics of the 
locality refused to come for assistance.  The Swasa 
Kasa Chintamoni 125mg TDS were added to control 
breathlessness and Dasamula Haritaki - 5gram BID to 
control abdominal discomfort and flatulence.  The 
redness of eyes and face disappeared on next day and 
oxygen saturation (95-96%) was stabilised on 3rd day 
of treatment. But intermittent oxygen therapy was 
advised and given for another day (Table no. 1). The 
patient had not received any steroid in any form 
during the course of treatment as steroid could 
precipitate sugar load and secondary infection.  
Table 1: Time line of the course of the disease, 
diagnosis, interventions and outcomes. 
Date  Symptom and 
evaluation 
Treatment  
1/4/2021 (D1) Body ache and 
mild fever  
No medicine  
2/4/2021 (D2) Headache with 
fever 
Paracetamol, Poly 
Vitamin, Zinc, Antibiotics 






bed ridden  




Consult doctor, advised 
hospitalisation in COVID 
Ward. 
10/4/2021(D10) Redness of eye, 
breathing 
difficulties  
Ayush-64 – 2tab TDS  
Sidhha Makardwaja 125 
mg OD  
Haldi Milk 200ml Bid  










Added Swasa Kasa 
Chintamoni 125 mg BID  
Oxygen therapy, Insulin - 
10-unit TDS and Temikind 









RTPCR -Positive  
Continued the same 
treatment with Oxygen 
support and Pranayama-  





Intermittent oxygen and 
Dasamula Haritaki  -5 
gram  BID after food 
added  




Oxygen withdrawn and 
medicine continued   
17/4/21 (D17) Appetite 
increased; 
weakness persist   
Mamsa Rasa 
22/4/21(D22) Able to do all Shifted to OHA and Anti 
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house hold works 
and no weakness  
hypertensive drug 
continued, 
Stopped all Ayurvedic 
Medication  
Follow up and Outcome measure  
The patient’s progress was followed on four hourly 
bases after the detection of severe symptoms through 
video call and was advised to inform if any 
emergency/change in status. The outcome was 
measured through clinical symptoms and oxygen 
saturation. The Initial Oxygen flow was 2.5lit/per hour 
continuously and was increased to 3.5 lit/hour to 
achieve SPO2 96%. Then intermittent oxygen with 
breathing exercise and Pranayama for 30 minutes 
twice were advised. The oxygen saturation and blood 
sugar were stabilised on third day of treatment. The 
oxygen therapy was stopped on 4th day of my 
treatment (D14).   
Table 2: Different Photographs of Patients with 
description  
Time line & Descriptions Photographs 
10/4/2021(D10) 
Redness of eye and face  
Breathing difficulties  
 
11/4/21(D11-13) 
Oxygen therapy in Home  
 
14/4/21 




Normal state of living without 
Ayurvedic medications  
 
DISCUSSION 
The patient was not prepared for admission in COVID 
hospital and had faith in Ayurvedic treatment and 
gave his consent as also the requisite undertaking for 
treatment. The Patient’s wife was given all four-hourly 
feedback during the crisis period and Ayurvedic 
physician trained her to administer Oxygen and 
insulin. The redness disappeared on 2nd day of therapy 
as Haridra has anti-allergic properties and milk is best 
for Pittaja Sotha. The Curcumin in Haridra inhibits 
spike protein, ACE2 receptors, mRNA expression and 
secretion of cytokines, IL-1β, IL-6, TNF-α, and IL-18.[12-
14] Siddha Makardwaja reduced Pitta and stabilized 
other two Dosas.[15] AYUSH-64 is proven drug for 
COVID-19 infection. Swasa Kasa Chintamani is a 
potent brocho-dilators and gives strength to Lungs 
with good internal integrity of renal and hepatic 
parameters.[16] The prescribed regimen was safe and 
effective without side effect as was observed in 
home-based treatment.  
CONCLUSION 
Ayurvedic Rasa-Rasayana and herbal combinations 
(AYUSH-64) are safe and effective in early 
Inflammatory phase of COVID-19 infection without 
the use of synthetic steroid along with minimum 
requisite measured dose of oxygen in home care set 
up through telehealth service. This preliminary case 
report may be used for Treatment of Corona 19 
infection in Moderate to Severe stage. 
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